Signed in
We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
GSK3640254 is an experimental medication developed by GlaxoSmithKline for the treatment of HIV. It belongs to a new class of therapies known as maturation inhibitors, which target a specific step in the virus’s lifecycle.